File size: 435kb | Date: 1 November 2015 | FSRH Consultation Response - PDF
The FSRH believes that at present there is a missed opportunity in maternity services. Within these services there is failure to utilise health care professionals to raise the issue of contraception both antenatally and postnatally.
File size: 100kb | Date: 1 November 2015 | New Product Reviews - PDF
How effective is 20mcgEE/3mgDRSP as contraception?
20mcgEE/3mg DRSP is of comparable effectiveness to other combined oral contraceptives. [1,2,3] A large US observational study reports lower failure rates amongst users of a 24/4 EE/DRSP regimen than a 21/7 EE/DRSP regimen. The study also suggests greater contraceptive effectiveness of a 24/4 EE/DRSP regimen than with a 24/4 regimen containing EE in combination with norethisterone.
File size: 376kb | Date: 1 October 2015 | FSRH Consultation Response - PDF
As an organisation focused on sexual and reproductive health – a key component of public health - the FSRH welcomes this review into the efficiency of existing public health indicators. This offers an opportunity to strengthen the PHOF in particular to take into account the sexual and reproductive health of the entire population.
File size: 44kb | Date: 1 October 2015 | Clinical Statements - PDF
A large observational study from the United States found that the risk of unintended pregnancy after Essure sterilisation was similar to that after surgical sterilisation. However just over 2% of women who had Essure sterilisation required a further operation related to the sterilisation procedure within a year.
File size: 49kb | Date: 1 October 2015 | Clinical Statements - PDF
Essure® is a form of female sterilisation which involves the hysteroscopic insertion of flexible micro-inserts into the proximal section of the fallopian tubes and is undertaken without general anaesthesia.
File size: 903kb | Date: 1 October 2015 | Current Clinical Guidance - PDF
This guidance provides evidence-based recommendations and good practice points for health professionals on the use of barrier methods for contraception and STI prevention. It is intended for any health care professional or health service providing contraception or conception advice in the UK.
File size: 61kb | Date: 1 September 2015 | Clinical Statements - PDF
The CEU supports the self administration of Sayana Press® because of its potential benefits to women and services. It offers women greater choice and more autonomy over their contraception and fertility.
File size: 569kb | Date: 1 September 2015 | FSRH Consultation Response - PDF
In its capacity as a specialist SRH organisation, the FSRH welcome the opportunity to outline to the Health Select Committee the challenges that are facing the delivery of contraceptive care in the primary care setting, both in the strict sense of General Practice clinics and the ways in which restrictions on Specialist Contraceptive Services are negatively impacting upon GP workload.
File size: 164kb | Date: 1 August 2015 | Clinical Statements - PDF
The BJOG: An International Journal of Obstetrics and Gynaecology today published an Australian study that considers the cost effectiveness of routine screening for Chlamydia trachomatis in all pregnant women aged 16 to 25 years.
File size: 524kb | Date: 1 August 2015 | FSRH Consultation Response - PDF
The FSRH welcomes this consultation on Local Authority health allocations for in-year savings in 2015/16. We, however, would like to express our grave concerns regarding the impact of such cuts on sexual and reproductive health if the Government’s plans go ahead. We also acknowledge and support the response from BASHH with regards to this consultation.